(Q37332716)

19 August 2017

1 reference

title

Human papillomavirus vaccination in the United Kingdom: what about boys? (English)

1 reference

19 August 2017

1 reference

Tamara Kubba

1

1 reference

19 August 2017

publication date

1 November 2008

1 reference

Reproductive Health Matters

19 August 2017

published in

1 reference

19 August 2017

volume

16

1 reference

19 August 2017

issue

32

1 reference

19 August 2017

page(s)

97-103

1 reference

Human papillomavirus and cervical cancer

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Genital human papillomavirus infection in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Opportunity was missed in choice of cervical cancer vaccine, health campaigners say.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Human papillomavirus vaccination in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Cost-effectiveness analyses of human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Economic evaluation of human papillomavirus vaccination in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Prevalence of HPV infection among men: A systematic review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Model for assessing human papillomavirus vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Role of herd immunity in determining the effect of vaccines against sexually transmitted disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

The theoretical population-level impact of a prophylactic human papilloma virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Prophylactic HPV vaccines: reducing the burden of HPV-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Chapter 2: The burden of HPV-related cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Spectrum of AIDS-associated malignant disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

Human papillomavirus vaccination in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

7 January 2021

Prevalence of human papillomavirus antibodies in young female subjects in England

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

7 January 2021

Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

7 January 2021

Human papillomavirus prevalence and type distribution in male anogenital sites and semen

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

7 January 2021

Increased risk of cervical neoplasia in consorts of men with penile condylomata acuminata

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

7 January 2021

High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

7 January 2021

Push to mandate HPV vaccine triggers backlash in USA

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932413-6

7 January 2021

10.1016/S0968-8080(08)32413-6

Identifiers

DOI

1 reference

19 August 2017

1 reference